Lv22
120 积分 2022-07-23 加入
Responsiveness of Serum C‐Reactive Protein, Interleukin‐17A, and Interleukin‐17F Levels to Ustekinumab in Psoriatic Arthritis: Lessons From Two Phase III, Multicenter, Double‐Blind, Placebo‐Controlled Trials
1小时前
待确认
PROTAC targeted protein degraders: the past is prologue
9天前
已完结
Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer
9天前
已完结
OA13.02 Global Phase 2 Randomized Trial of BNT327 (Pumitamig; PD-L1 x VEGF-A bsAb) + Chemotherapy for 1L ES-SCLC: Dose Optimization Analysis
22天前
已关闭
OA13.02 Global Phase 2 Randomized Trial of BNT327 (Pumitamig; PD-L1 x VEGF-A bsAb) + Chemotherapy for 1L ES-SCLC: Dose Optimization Analysis
23天前
已关闭
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives
1个月前
已完结
Identification and characterization of asparagine deamidation in the light chain CDR1 of a humanized IgG1 antibody
1个月前
已完结
Development of Biopharmaceutical Drug-Device Products
1个月前
已完结
TL1A Inhibition in Inflammatory Bowel Disease: A Pipeline Review
1个月前
已完结
皖公网安备34019202002308
